Magellan Life Sciences
PrivateLast Round
Grant
Sep 1, 2023
Est. Valuation
$3.54M
Total Funding Raised
$2.71M
Company Overview
Magellan Life Sciences operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Grant round in September 2023.
Magellan Life Sciences is a synthetic biology company that discovers and develops plant-inspired proteins for commercial applications in the food and beverage industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Magellan Life Sciences Comparables
Compare Magellan Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pentasweet | 87% | |
| Amai Proteins | 80% | |
| Manus Bio | 78% |
For institutional investors. Book with your work email.
Magellan Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Aug 1, 2023 | ||||
| Seed | Jun 9, 2021 | ||||
| Grant | Jun 1, 2021 | ||||
| Seed | Nov 5, 2020 | ||||
Accelerator | Jan 17, 2018 |
For institutional investors. Book with your work email.
Magellan Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Roquette Ventures | Seed |
| RebelBio | Accelerator |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2023
$880K grant received from Innovate UK.
- Jun 9, 2021
Seed round led by Roquette Ventures
For institutional investors. Book with your work email.
Magellan Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Magellan Life Sciences's valuation, stock price, and market status.
Is Magellan Life Sciences a public or private company?
Magellan Life Sciences is a private company.
What is the current stock price of Magellan Life Sciences?
Magellan Life Sciences is a private company, so its shares have no public market price. Caplight tracks Magellan Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Magellan Life Sciences worth (valuation)?
Magellan Life Sciences's valuation is estimated at $3.5M based on funding round data.
Can I buy Magellan Life Sciences stock?
Magellan Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Magellan Life Sciences's last funding round?
Magellan Life Sciences's most recent funding round was Grant on September 1, 2023.
Who are the main investors in Magellan Life Sciences?
Key investors in Magellan Life Sciences include Roquette Ventures.
Will Magellan Life Sciences IPO soon?
No public IPO plans have been announced for Magellan Life Sciences.
How can I track Magellan Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Magellan Life Sciences's shares on secondary markets.